This New Treatment Could Save the Lives of Babies. But It Costs $2.1 Million.
The Food and Drug Administration on Friday approved a gene therapy for spinal muscular atrophy, a rare muscle-wasting disease that, in its most severe form, kills many babies before they turn 2. The price will be $2.1 million, believed to be highest ever set for a one-time treatment. The therapy, to be sold as Zolgensma,…